MacroGenics Cost Of Revenue from 2010 to 2024

MGNX Stock  USD 3.44  0.25  6.78%   
MacroGenics Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 7.8 M in 2024. During the period from 2010 to 2024, MacroGenics Cost Of Revenue regression line of annual values had r-squared of  0.01 and arithmetic mean of  84,669,727. View All Fundamentals
 
Cost Of Revenue  
First Reported
2011-12-31
Previous Quarter
4.6 M
Current Value
1.9 M
Quarterly Volatility
18.7 M
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of MacroGenics over the last few years. Cost of Revenue is found on MacroGenics income statement and represents the costs associated with goods and services MacroGenics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is MacroGenics' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Very volatile
   Cost Of Revenue   
       Timeline  

MacroGenics Cost Of Revenue Regression Statistics

Arithmetic Mean84,669,727
Geometric Mean46,637,856
Coefficient Of Variation83.05
Mean Deviation58,521,685
Median56,476,000
Standard Deviation70,320,208
Sample Variance4944.9T
Range192.7M
R-Value(0.1)
Mean Square Error5277.2T
R-Squared0.01
Significance0.74
Slope(1,495,220)
Total Sum of Squares69229T

MacroGenics Cost Of Revenue History

20247.8 M
20238.2 M
20227.4 M
20212.7 M
2020193.2 M
2019195.3 M
2018190.8 M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue8.2 M7.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.